AstraZeneca PLC
1580.25
17-2月-25 07:47:58
15 分の遅延
株式
-3.25
-0.21%
本日の幅
1575.00 - 1585.00
ISIN
N/A
ソース
NASD.OMX SE
-
AZN :FDA Oks Wainua For Treatment Of Polyneuropathy Of Hereditary Transthyretin-Mediated Amyloidosis
21 12 2023 19:47:36 提供 NASDAQ US Markets
-
AstraZeneca sheds £15 billion of market cap as weight-loss-pill data underwhelms investors
21 12 2023 19:44:53 提供 MarketWatch
-
AstraZeneca Will Acquire RSV Vaccine Developer Icosavax For $1.1 Billion
12 12 2023 03:30:35 提供 Forbes - World
-
AstraZeneca To Buy US-based Icosavax In Around $1.1 Bln Deal
12 12 2023 02:42:28 提供 NASDAQ US Markets
-
AstraZeneca : Phase III Trial Data Show Danicopan Sustained Clinical Improvements In PNH
10 12 2023 22:22:28 提供 NASDAQ US Markets
-
AstraZeneca Just Joined the AI Drug Development Craze, but Is It a Buy in 2024?
10 12 2023 08:09:34 提供 NASDAQ US Markets
-
Is Now the Right Time to Buy AstraZeneca Stock?
10 12 2023 06:46:15 提供 NASDAQ US Markets
-
Absci (ABSI) Up on AstraZeneca Deal to Design New Cancer Therapy
05 12 2023 08:27:21 提供 NASDAQ Stocks
-
Absci, AstraZeneca Join To Deliver AI-designed Antibody Against Oncology Target
04 12 2023 07:12:31 提供 NASDAQ US Markets
-
AstraZeneca To Discontine STABILIZE-CKD, DIALIZE-Outcomes Trials Under CRYSTALIZE Programme
01 12 2023 01:39:09 提供 NASDAQ US Markets
-
AstraZeneca Launches Evinova Healthtech Business
20 11 2023 08:21:15 提供 NASDAQ US Markets
-
Pharma Stock Roundup: FDA Okays AZN's Capivasertib & MRK's Keytruda Expanded Use
17 11 2023 08:20:24 提供 NASDAQ Stocks
-
AstraZeneca: Truqap Plus Faslodex Approved In US For HR+ Breast Cancer
17 11 2023 02:04:07 提供 NASDAQ US Markets
-
Interesting AZN Put And Call Options For July 2024
16 11 2023 10:57:01 提供 NASDAQ Stocks
-
AstraZeneca : Phase III Trial Of Imfinzi + Chemoradiotherapy In Lung Cancer Fails To Meet Main Goal
14 11 2023 02:55:47 提供 NASDAQ US Markets
-
AstraZeneca (AZN) Beats on Q3 Earnings & Sales, Ups 2023 View
10 11 2023 08:14:44 提供 NASDAQ Stocks
-
AstraZeneca Plc (AZN) Q3 2023 Earnings Call Transcript
09 11 2023 17:26:41 提供 NASDAQ US Markets
-
AstraZeneca Paying Up To $2 Billion For Experimental Obesity Pill—As Weight Loss Drug Market Grows
09 11 2023 08:57:51 提供 Forbes - World
-
09 11 2023 05:19:20 提供 MarketWatch
-
09 11 2023 04:10:57 提供 MarketWatch